| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.9M | -21.9% |
| Cost of Revenue | $7.6M | +65.7% |
| Gross Profit | $2.3M | -62.8% |
| R&D Expense | $2.4M | -41.8% |
| SG&A Expense | $17.8M | -32.5% |
| Interest Expense | $4.0M | +39.7% |
| Pre-tax Income | -$80K | +99.9% |
| Net Income | -$79.7M | +47.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | +15.2% |
| Accounts Receivable | $650K | -59.3% |
| Inventory | $4.0M | -62.4% |
| Current Assets | $12.0M | -44.5% |
| Total Assets | $24.9M | -71.9% |
| Current Liabilities | $27.9M | +11.2% |
| Long-term Debt | $1.9M | -84.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +75.9% |
| Capital Expenditures | $165K | -94.7% |
| Investing Cash Flow | $14.9M | +257.7% |
| Financing Cash Flow | -$6.5M | -113.0% |
| Free Cash Flow | -$9.7M | +77.2% |
| Total Liabilities |
| $39.9M |
| -1.1% |
| Stockholders' Equity | -$15.0M | -131.2% |